Alnylam Pharmaceuticals owns U.S. Patent Nos. 11,246,933 (parent) and 11,382,979 (child). These patents relate to biodegradable lipids and their use for the delivery of active agents such as nucleic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results